Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Liver fibrosis is one of the leading causes of morbidity and mortality worldwide of which no acceptable therapy exists. Accumulating evidence supports that glioma‐associated oncogene homologue 1 (GLI1) is a potentially important therapeutic target for liver fibrosis. This study investigates the antifibrotic activities and potential mechanisms of Physalin B (PB), a natural Solanaceae compound.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>Mice subjected to carbon tetrachloride (CCl<sub>4</sub>) challenge and bile duct ligation (BDL) were used to study the antifibrotic effects of PB <i>in vivo</i>. Mouse primary hepatic stellate cells (pHSCs) and human HSC line LX‐2 also served as an <i>in vitro</i> liver fibrosis model. Liver fibrogenic genes, GLI1 and GLI1 downstream genes were examined using western blot and quantitative real‐time PCR (qRT‐PCR). GLI1 acetylation and LAP2α‐HDAC1 interaction were analyzed by coimmunoprecipitation. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>In animal models, PB administration attenuated hepatic histopathological injury, collagen accumulation, and reduced the expression of fibrogenic genes. PB dose‐dependently suppressed fibrotic marker expression in LX‐2 cells and mouse pHSCs. Mechanistic studies showed PB inhibited GLI activity in a non‐canonical Hedgehog signaling. PB blocked lamina‐associated polypeptide 2 α (LAP2α)/histone deacetylase 1 (HDAC1) complex formation thereby inhibited HDAC1mediated GLI1 deacetylation. PB upregulated the acetylation of GLI1, downregulated the expression of GLI1 and subsequently inhibiting HSC activation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions and Implications</h3><p>PB exerted potent antifibrotic effects <i>in vitro</i> and <i>in vivo</i> by disrupting the LAP2α/HDAC1 complex, increasing GLI1 acetylation and inactivating GLI1. This indicates that PB may be a potential therapeutic candidate for the treatment of liver fibrosis. </p></section>

The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells

The in Vitro Effects of Phospholipase D1-mTOR Axis in Liver Fibrogenesis.

Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF‐κB and the PI3K/Akt Signaling Pathway

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

Physalin B attenuates liver fibrosis via suppressing LAP2-HDAC1-mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation

Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1 mediated deacetylation of GLI1 and hepatic stellate cell activation

TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis

Hepatic-specific Lipin-1 Deficiency Exacerbates Experimental Alcohol-Induced Steatohepatitis in Mice

Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway

Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis

TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition

KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression

Physalin D Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking TGF-β/Smad and YAP Signaling

HIF-1α-upregulated lncRNA-H19 regulates lipid droplet metabolism through the AMPKα pathway in hepatic stellate cells

Physalin B attenuates liver fibrosis via suppressing LAP2α–HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation

Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway

Linc-Scrg1 Accelerates Liver Fibrosis by Decreasing RNA-binding Protein Tristetraprolin.

The role of Sirtuin 1 in regulation of fibrotic genes expression in pre-adipocytes

Lipoxin A4 Inhibited the Activation of Hepatic Stellate Cells -T6 Cells by Modulating Profibrotic Cytokines and NF-κB Signaling Pathway.